Gluconorm G2 Forte Tablet PR

Introduction

Gluconorm G2 Forte Tablet PR 15s is prescribed to manage blood glucose levels in individuals diagnosed with type 2 diabetes.

It belongs to the class of oral hypoglycemics, which are used to treat diabetes by lowering blood sugar levels. It achieves this by increasing the amount of insulin released by the pancreas and improving the body's insulin utilization. By doing so, it helps to regulate blood glucose levels more effectively.

The maximum effects of this medicine may take up to 2 weeks of regular dosing to develop, with peak effects seen within 23 hours for immediate-release forms and 4 to 8 hours for slow-release forms.

Patients prescribed it should adhere to their healthcare provider's recommendations regarding dosage and duration of treatment.

It is crucial to report any persistent symptoms or adverse effects promptly.

How it works

Gluconorm G2 Forte Tablet PR 15s's a mix of two diabetes medicines: Glimepiride and Metformin. Glimepiride helps by making the pancreas release more insulin to lower blood sugar. Metformin works by reducing how much sugar the liver produces, slowing down sugar absorption from the intestines, and making the body respond better to insulin.

How to take

["Follow your doctor's advice on the dose and duration","Ingest the tablet whole; avoid chewing, crushing, or breaking","Gluconorm G2 Forte Tablet PR 15s is meant to be taken with food","For optimal results, consume it with a meal","Adhere strictly to the prescribed dose and treatment duration","Consult your doctor for any concerns or adjustments to the medication routine"]

Adverse drug effect

Gluconorm G2 Forte Tablet PR, a combination of metformin and glimepiride, may cause side effects like nausea, diarrhea, low blood sugar, and liver or blood disorders. Monitor for symptoms such as persistent hypoglycemia, yellowing of the skin or eyes, or unusual bleeding. Consult your doctor if side effects persist or worsen. Maintain a healthy lifestyle and follow dosage instructions for safe use.

@2024 BHU Banaras Hindu University